Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 48.47
-0.16 (-0.33%)
At close: Mar 25, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 660.96 million as of March 27, 2026. Its market cap has increased by 173.23% in one year.
Market Cap
660.96M
Enterprise Value
645.02M
Revenue
n/a
Ranking
n/a
PE Ratio
76.86
Stock Price
48.47
Market Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 660.96M, an increase of 2,931.75%. That is a compound annual growth rate of 19.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 660.96M | 29.21% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarey Drugs & Pharmaceuticals | 1.59B |
| Accretion Nutraveda | 1.44B |
| Panchsheel Organics | 1.33B |
| Smruthi Organics | 1.22B |
| Kimia Biosciences | 1.20B |
| Tyche Industries | 1.07B |
| Resonance Specialties | 966.12M |
| Krebs Biochemicals & Industries | 940.69M |